Peripheral T-cell lymphoma Ann Arbor staging is advanced when it is stage III.
Peripheral T-cell lymphoma belongs to a group of non-Hodgkin’s lymphomas, including angioimmunoblastic T-cell lymphoma, peripheral T-cell lymphoma anaplastic, mesenchymal large cell lymphoma, and NK/T-cell lymphoma.
Disease staging adopts the Ann Arbor staging criteria, which can be divided into stages I, II, III, and IV, and peripheral T-cell lymphoma in stage III belongs to the advanced stage.
Peripheral T-cell lymphoma often involves lymphatic tissues other than bone marrow, such as intestines, skin, lymph nodes, spleen, etc. It is an aggressive non-Hodgkin’s lymphoma with rapid disease progression, and requires active treatment, including surgery, chemotherapy, radiotherapy, targeted therapy, etc. Drugs include cyclophosphamide, vincristine and other drugs. Drugs include cyclophosphamide, vincristine, cedarbenazine and so on.
It is recommended that patients with peripheral T-cell lymphoma should consult the hematology department in time, complete PET-CT, bone marrow aspiration and other relevant examinations to evaluate their conditions, and then formulate individualized treatment plans according to their specific conditions and actively treat them under the guidance of physicians.